23.15
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $23.15, with a volume of 6.33M.
It is down -2.98% in the last 24 hours and down -5.20% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
See More
Previous Close:
$23.86
Open:
$23.9
24h Volume:
6.33M
Relative Volume:
0.86
Market Cap:
$11.89B
Revenue:
$11.89B
Net Income/Loss:
$-560.00M
P/E Ratio:
-21.05
EPS:
-1.1
Net Cash Flow:
$191.00M
1W Performance:
+3.44%
1M Performance:
-5.20%
6M Performance:
-19.59%
1Y Performance:
-36.26%
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(224) 948-2000
Address
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
BAX
Baxter International Inc
|
23.15 | 12.25B | 11.89B | -560.00M | 191.00M | -1.10 |
![]()
ISRG
Intuitive Surgical Inc
|
449.69 | 162.16B | 9.15B | 2.63B | 1.99B | 7.1661 |
![]()
BDX
Becton Dickinson Co
|
191.99 | 55.49B | 21.39B | 1.61B | 2.55B | 5.5609 |
![]()
RMD
Resmed Inc
|
281.38 | 40.66B | 5.15B | 1.40B | 1.65B | 9.5082 |
![]()
ALC
Alcon Inc
|
76.82 | 38.26B | 10.03B | 1.07B | 1.39B | 2.1549 |
![]()
WST
West Pharmaceutical Services Inc
|
268.07 | 19.60B | 2.96B | 487.70M | 344.00M | 6.68 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-04-25 | Downgrade | Stifel | Buy → Hold |
Aug-01-25 | Downgrade | Goldman | Buy → Neutral |
Feb-26-25 | Resumed | Goldman | Buy |
Feb-24-25 | Upgrade | Argus | Hold → Buy |
Feb-20-25 | Resumed | Barclays | Overweight |
Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
May-30-24 | Initiated | Goldman | Neutral |
May-10-24 | Downgrade | TD Cowen | Buy → Hold |
May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
Mar-29-23 | Initiated | UBS | Neutral |
Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
Oct-18-22 | Initiated | Barclays | Overweight |
Oct-12-22 | Initiated | Jefferies | Hold |
Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
Mar-02-22 | Resumed | BofA Securities | Buy |
Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
Feb-18-22 | Reiterated | Raymond James | Outperform |
Feb-18-22 | Reiterated | Stifel | Buy |
Feb-18-22 | Reiterated | UBS | Neutral |
Feb-18-22 | Reiterated | Wells Fargo | Overweight |
Feb-11-22 | Initiated | Goldman | Neutral |
Jan-07-22 | Resumed | Citigroup | Buy |
Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
May-25-21 | Initiated | Barclays | Equal Weight |
Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
Jan-06-21 | Downgrade | UBS | Buy → Neutral |
Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
Sep-04-20 | Downgrade | Argus | Buy → Hold |
Jun-24-20 | Initiated | Oppenheimer | Outperform |
Mar-19-20 | Upgrade | Stifel | Hold → Buy |
Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Mar-05-20 | Initiated | Citigroup | Neutral |
Feb-13-20 | Initiated | Goldman | Buy |
Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
Nov-02-18 | Upgrade | Argus | Hold → Buy |
Oct-16-18 | Initiated | Barclays | Underweight |
May-17-18 | Resumed | Piper Jaffray | Overweight |
Feb-06-18 | Reiterated | Citigroup | Neutral |
Jan-03-18 | Initiated | Evercore ISI | Outperform |
Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
Risk vs reward if holding onto Baxter International Inc.Market Movers & High Accuracy Buy Signal Tips - newser.com
How the Narrative for Baxter International Is Evolving Amid Leadership Changes and Mixed Analyst Views - Yahoo
How Baxter International Inc. stock performs during market turbulenceDip Buying & Safe Swing Trade Setups - newser.com
Detecting price anomalies in Baxter International Inc. with AI2025 EndofYear Setup & Fast Entry High Yield Tips - newser.com
Is Baxter International Inc. stock attractive for growth fundsWeekly Trade Recap & Low Risk Profit Maximizing Plans - newser.com
1 Healthcare Stock with Exciting Potential and 2 Facing Challenges - The Globe and Mail
Measuring Baxter International Inc.’s beta against major indices2025 Year in Review & Real-Time Stock Entry Alerts - newser.com
How Baxter International Inc. (BAX) Affects Rotational Strategy Timing - news.stocktradersdaily.com
First bridge replacement finished after Helene, servicing Baxter Healthcare - WCNC
Will Baxter International Inc. stock beat Nasdaq index returns2025 Major Catalysts & High Accuracy Trade Alerts - newser.com
Is Baxter International Inc. stock a buy on weaknessQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - newser.com
How Baxter International Inc. (BTL) stock performs in volatility spikesEarnings Trend Report & AI Enhanced Trading Alerts - newser.com
Precision Trading with Baxter International Inc. (BAX) Risk Zones - news.stocktradersdaily.com
Healthcare Industry Resilience Collaborative (HIRC) Awards Gold Level Resiliency Badge to Baxter International Inc. (BAX) - MSN
What analysts say about Baxter International Inc stockGeopolitical Risk Analysis & Breakout Portfolio Performance - earlytimes.in
What drives PYXS stock priceRisk-Reward Ratio Analysis & Small Budget Trading Ideas - earlytimes.in
Baxter names new Senior VP and Chief Accounting Officer - MSN
Can Baxter International Inc. (BTL) stock sustain free cash flowWeekly Market Report & Capital Efficiency Focused Ideas - newser.com
Will Baxter International Inc. stock benefit from Fed rate cuts2025 Volume Leaders & Low Risk High Win Rate Stock Picks - newser.com
Is Baxter International Inc BTL a good long term investmentEquity Performance Review & Rapid Capital Gain - earlytimes.in
Baxter International: Medical Business In Need Of A Save Itself (NYSE:BAX) - Seeking Alpha
Advanced analytics toolkit walkthrough for Baxter International Inc.Market Growth Summary & Precise Swing Trade Alerts - newser.com
Baxter International Inc. (BAX) Stock Analysis: Navigating a 30% Potential Upside Amidst Industry Challenges - DirectorsTalk Interviews
Comparing Baxter International Inc. in custom built stock radars2025 Big Picture & High Win Rate Trade Alerts - newser.com
Should FDA Clearance and Supply Chain Risks Drive a Reassessment of Baxter International’s (BAX) Digital Health Strategy? - simplywall.st
Baxter International (BAX): Valuation Check After U.S. National Security Probe Rattles Medical Device Sector - Yahoo Finance
I'm the former CEO of a $12 billion health care company and I serve on many boards. AI deserves a seat at the table - Fortune
U.S. Home Healthcare Market Size, Share & Trends Analysis Report 2025-2033: Focus on Neurological & Mental Disorders, Diabetes & Kidney Disorders, Cancer, Wound Care - GlobeNewswire Inc.
Baxter earns gold level resiliency badge for critical medical supplies - Investing.com India
Baxter earns gold level resiliency badge for critical medical supplies By Investing.com - Investing.com Canada
Baxter is First Manufacturer to Achieve Gold Resiliency Badge for IV Solutions, Nutrition Solutions and Premix Drugs from Healthcare Industry Resilience Collaborative (HIRC) - The Joplin Globe
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):